Senmiao Technology Declares Non-Reliance on Q3 2025 Financials, Citing Warrant Misclassification
AIHS sits 60% above its 52-week low of $0.833 on light trading volume (0.2× avg).
Summary
Senmiao Technology announced that its Q3 2025 financial statements are unreliable due to a $4.925 million misclassification of warrants, necessitating a restatement.
Key Events · Corporate Governance and Compliance · AIHS
-
Non-Reliance on Financial Statements
The Audit Committee concluded that the unaudited condensed financial statements for the period ended December 31, 2025, originally filed on February 13, 2026, should no longer be relied upon.
-
Reason for Non-Reliance
The company misclassified 905,000 pre-funded warrants and 4,510,000 private placement warrants as equity instruments, which should have been classified as derivative liabilities and measured at fair value.
-
Significant Financial Misstatement
As of December 31, 2025, derivative liabilities were understated by $4.925 million, and additional paid-in capital was overstated by $2.829 million.
-
Restatement Planned
The company intends to file a restatement of its unaudited condensed financial statements for the affected period.
Analysis · AIHS · Trade & Services
The Audit Committee has determined that the company's previously issued unaudited financial statements for the quarter ended December 31, 2025, can no longer be relied upon. This is a critical event, as it indicates significant accounting errors, specifically the misclassification of warrants as equity instead of derivative liabilities. The magnitude of the misstatement, with derivative liabilities understated by $4.925 million against a market capitalization of $6.06 million, is substantial and points to severe internal control weaknesses that were previously disclosed. A restatement will be filed, which could further impact investor confidence and potentially complicate future financing efforts for the company.
At the time of this filing, AIHS was trading at $1.33 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $6.1M. The 52-week trading range was $0.83 to $8.26. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.